feed,title,long_url,short_url
Benzinga,Application Deadline Extended for 'Still Standing' -- A One-Year Artist Residency Providing Free Housing For Creatives In New York City,https://www.benzinga.com/pressreleases/20/11/n18358137/application-deadline-extended-for-still-standing-a-one-year-artist-residency-providing-free-housin,https://j.mp/3kmC2w8
Benzinga,Narconon Europe Celebrates 5 Years of Saving Lives in Denmark,https://www.benzinga.com/pressreleases/20/11/n18358109/narconon-europe-celebrates-5-years-of-saving-lives-in-denmark,https://j.mp/3lzzZ9y
Benzinga,"Accenture Completes Acquisition of Avenai, Ottawa-based Business and Technology Consultancy",https://www.benzinga.com/pressreleases/20/11/n18358100/accenture-completes-acquisition-of-avenai-ottawa-based-business-and-technology-consultancy,https://j.mp/3kA5TS0
Benzinga,Algernon Pharmaceuticals Provides Update on its Ifenprodil Phase 2 Clinical Trials Featured on BioPub Webcast Hosted by Dr. KSS MD PhD,https://www.benzinga.com/pressreleases/20/11/g18358074/algernon-pharmaceuticals-provides-update-on-its-ifenprodil-phase-2-clinical-trials-featured-on-bio,https://j.mp/38GruFU
Benzinga,VirTra's Chief Financial Officer Judy Henry to Retire in December,https://www.benzinga.com/pressreleases/20/11/g18358068/virtras-chief-financial-officer-judy-henry-to-retire-in-december,https://j.mp/3eVDzYU
Benzinga,Larimar Therapeutics to Participate in Upcoming Investor Conferences,https://www.benzinga.com/pressreleases/20/11/g18358056/larimar-therapeutics-to-participate-in-upcoming-investor-conferences,https://j.mp/3ktppiS
Benzinga,"NGM Bio Presents Phase 1 Safety and Pharmacokinetics Data for NGM621, an Anti-Complement C3 Antibody, in Patients with Geographic Atrophy at the American Academy of Ophthalmology 2020 Virtual",https://www.benzinga.com/pressreleases/20/11/g18358052/ngm-bio-presents-phase-1-safety-and-pharmacokinetics-data-for-ngm621-an-anti-complement-c3-antibod,https://j.mp/3lyaZPO
